Dialectics and Implications of Natural Neurotropic Autoantibodies in Neurological Disease and Rehabilitation
2004

Natural Neurotropic Autoantibodies in Neurological Disease

Sample size: 367 publication Evidence: moderate

Author Information

Author(s): A.B. POLETAEV, A.A. ABROSIMOVA, M.A. SOKOLOV, A.B. GEKHT, V.V. ALFEROV, E.I. GUSEV, T.YA. NIKOLAEV, C. SELMI

Primary Institution: Medical Research Center 'Immunculus'

Hypothesis

The study investigates the role of natural idiotypic and anti-idiotypic autoantibodies against neuro-antigens in neurological disorders.

Conclusion

Changes in the production of neurotropic autoantibodies may have a positive homeostatic role in neurological disorders.

Supporting Evidence

  • Patients with ischemic stroke showed variable levels of autoantibodies at different recovery stages.
  • Altered autoantibody levels were found in 97% of schizophrenia patients.
  • Healthy individuals maintained normal levels of neurotropic autoantibodies.

Takeaway

The study found that certain antibodies in the blood can change after a stroke or in mental illnesses, which might help the body recover.

Methodology

The study analyzed serum samples from patients with ischemic stroke, schizophrenia, and healthy individuals using ELISA to measure autoantibody levels.

Potential Biases

Potential biases in patient selection and the interpretation of serological responses.

Limitations

The study's cross-sectional nature may limit the ability to establish causation.

Participant Demographics

109 patients with ischemic stroke (63 females, average age 65), 38 patients with schizophrenia (22 females, average age 42), and 220 healthy subjects (155 females, average age 36).

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1080/10446670410001722221

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication